NCT07532577

Intranasal Insulin to Prevent Intensive Care Unit Delirium

← Hub

Registry fields

Overall status: COMPLETED
Conditions: Delirium - Postoperative
Study type: INTERVENTIONAL
Phase: PHASE2, PHASE3
Primary purpose: PREVENTION
Intervention type: DRUG
Interventions: Intranasal insulin-40U, Intranasal sodium chloride 0.9%
Lead sponsor: Radboud University Medical Center (OTHER)

Cached at: 2026-08-05 00:45:21

View on ClinicalTrials.gov

Brief summary

This study aims to assess the feasibility, tolerability, and exploratory efficacy of intranasal insulin to prevent delirium in ICU patients aged ≥65 years after complex elective cardiac surgery with cardiopulmonary bypass

Contact

Need a report or Korean medical writing based on this trial?

Request a report Medical writing Custom research report